According to an article coauthored by Mark Cohen in the September 2021 issue of Nature Biotechnology, government planning and targets for patents in China, while boosting overall quantity, negatively impacted overall quality. Quality concerns were manifested by a clear end-of-year trough in forward citations of patents filed near year’s end.
Chinese TM and Design Filings in Europe Showing Continued Positive Trends
EUIPO has issued a report “China EUTM and RCD Focus” on 10 years of China trademark (TM) and registered community design (RCD) filings in the EU. The report also details the impact […]
Recent Research of USPTO
This is the first in a series of blogs on recent research. The USPTO just released its report on Trademarks and Patents in China, The Impact of Non-Market Factors on Filing Trends […]
100 Priority IP Projects for 2020
What does the recently released CNIPA document listing “100 Projects in 2020 to Deeply implement the National Intellectual Property Strategy to Accelerate the Construction of the Intellectual Property Powerful Country Promotion Plan” […]
IPR Outcomes in the 26th JCCT
Here are the IP outcomes of the 26th Joint Commission on Commerce and Trade, concluded early in November 2015 in Guangzhou. The IP-related outcomes appear primarily in three different places in the […]
China’s Patent Domination?
Thomson Reuters just released a new report on China’s Innovation Quotient (Trends in Patenting and China’s Trends in Global Innovation). This is the fourth in a very useful multi-year series on Chinese […]
Understanding Service Inventions – Data
I recently gave a talk on service inventions in China – inventions made while in the employ of a company, using its materials and tools. SIPO has published a draft of its […]
China IPR - Intellectual Property Developments in China 